SAN FRANCISCO, Nov. 27, 2017 /PRNewswire/ -- Nektar
Therapeutics (Nasdaq: NKTR) announced today that its corporate
presentation will be webcast at the upcoming Piper Jaffray
29th Annual Healthcare Conference in New York City
on Tuesday, November 28, 2017 at 5:10 p.m.
ET.
The presentation will be accessible via a Webcast through a link
posted on the Investors, Events Calendar section of the Nektar
website: http://ir.nektar.com/events.cfm. This Webcast will be
available for replay until December 29, 2017.
About Nektar
Nektar Therapeutics is a research-based, development stage
biopharmaceutical company whose mission is to discover and develop
innovative medicines to address the unmet medical needs of
patients. Our R&D pipeline of new investigational medicines
includes treatments for cancer, auto-immune disease and chronic
pain. We leverage Nektar's proprietary and proven chemistry
platform in the discovery and design of our new therapeutic
candidates. Nektar is headquartered in San
Francisco, California, with additional operations
in Huntsville, Alabama and Hyderabad, India.
Further information about the company and its drug development
programs and capabilities may be found online
at http://www.nektar.com.
Contact:
Investors
Jennifer Ruddock of Nektar Therapeutics
415-482-5585
View original
content:http://www.prnewswire.com/news-releases/nektar-to-webcast-presentation-at-the-piper-jaffray-29th-annual-healthcare-conference-in-new-york-city-300562135.html
SOURCE Nektar Therapeutics